Cantor Fitzgerald analyst Steven Halper upgraded HealthEquity to Overweight with an $82 price target. The stock closed the trading day down 4%, or $2.46, to $59.63. Despite the recent pullback in the shares, HealthEquity’s fundamentals remain strong as the company continues to benefit from adoption of health savings accounts, Halper tells investors in a research note. The analyst believes the recent pullback in the stock is overdone and creates an attractive entry point.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.